Baker Bros. Advisors LP Vir Biotechnology, Inc. Transaction History
Baker Bros. Advisors LP
- $9.86 Billion
- Q2 2025
A detailed history of Baker Bros. Advisors LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 542,539 shares of VIR stock, worth $3.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
542,539
Previous 542,539
-0.0%
Holding current value
$3.4 Million
Previous $3.52 Million
22.22%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
247Shares Held
109MCall Options Held
350KPut Options Held
150K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$105 Million0.67% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$82.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$81 Million34.47% of portfolio
-
State Street Corp Boston, MA5.25MShares$32.9 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $832M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...